Science Explorer Interactive view Map
Company · Seongnam-si · South Korea

Genexine (South Korea)

genexine.comROR OpenAlex
Research works
32
▲ 24% vs 2013–17
Citations
790
25.0 per fractional work
Top-10% rate
19.2%
record average 16.5%
Open access
56%
world 28%

Not ranked overall: Genexine (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.13× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.08× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 18.54× its world share, 2 worksImmunology and Micro…Chemistry: 1.37× its world share, 0 worksChemistryEngineering: 0.54× its world share, 1 worksEngineeringMedicine: 2.41× its world share, 4 worksMedicineVeterinary: 22.28× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 22.3×. Every wedge is a field page.

Which keywords describe research at Genexine (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunity, Antigen Presentation, Immunotherapy, Innate Immunity, Glycosylation, Dendritic Cells and Monoclonal Antibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Immunotherapy4▲ 84×2 topics
  2. Immunity3▲ 30×5 topics
  3. Antigen Presentation3▲ 91×2 topics
  4. Epidemiology3▲ 2.2×15 topics
  5. Immunotherapy3▲ 14×10 topics
  6. Innate Immunity3▲ 26×3 topics
  7. Glycosylation3▲ 39×3 topics
  8. Dendritic Cells3▲ 72×2 topics
  9. Monoclonal Antibodies2▲ 55×3 topics
  10. Tumor Antigen2▲ 97×1 topic
  11. Vaccine Adjuvants2▲ 97×1 topic
  12. Therapeutic Antibodies2▲ 58×2 topics
  13. Cancer2▲ 5.2×11 topics
  14. Inflammation2▲ 2.9×13 topics
  15. Autoimmunity2▲ 26×2 topics
  16. Gene Therapy2▲ 19×3 topics
  17. Lymphoma2▲ 33×3 topics
  18. TGF-ß2▲ 30×2 topics
  19. Antibody Engineering2▲ 48×1 topic
  20. Fc Receptors2▲ 48×1 topic
  21. Tumor Regression2▲ 55×2 topics
  22. CD4+CD25+1▲ 61×1 topic
  23. Chemotherapy1▲ 6.4×3 topics
  24. Foxp31▲ 61×1 topic
  25. Leukemia1▲ 67×2 topics
  26. Monoclonal Antibody1▲ 66×2 topics
  27. CAR T Cells1▲ 91×1 topic
  28. Chimeric Antigen Receptor1▲ 91×1 topic
  29. NK Cell Recognition1▲ 36×1 topic
  30. Natural Killer Cells1▲ 36×1 topic
  31. Immune System1▲ 10×3 topics
  32. Targeted Therapy1▲ 16×3 topics
  33. ALK Inhibitors1▲ 57×1 topic
  34. Biopharmaceuticals1▲ 46×2 topics
  35. Breast Cancer1▲ 12×1 topic
  36. EGFR Mutations1▲ 57×1 topic
  37. Genomic Profiling1▲ 33×2 topics
  38. HER21▲ 106×1 topic
  39. Immunogenicity1▲ 61×2 topics
  40. Vaccine1▲ 7.9×6 topics

Which research topics does Genexine (South Korea) publish most on?

By volume in 2022–2025: Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Immunotherapy and Immune Responses and T-cell and B-cell Immunology.

Lung Cancer Treatments a…1Lung Cancer Treatments and Mutations: 1 fractional worksHER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksT-cell and B-cell Immunology: 0 fractional worksViral Infectious Diseases and Gene Expression in Insects: 0 fractional worksVeterinary Oncology Research: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksTerahertz technology and applications: 0 fractional worksMolecular Communication and Nanonetworks: 0 fractional worksMicrobial Metabolic Engineering and Bioproduction: 0 fractional works
Pulmonary and Respiratory MedicineOncologyImmunologyMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  2. 2 HER2/EGFR in Cancer Research Oncology 1 works
  3. 3 Immunotherapy and Immune Responses Immunology 1 works
  4. 4 T-cell and B-cell Immunology Immunology 0 works
  5. 5 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  6. 6 Veterinary Oncology Research Pulmonary and Respiratory Medicine 0 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 0 works
  8. 8 Terahertz technology and applications Electrical and Electronic Engineering 0 works
  9. 9 Molecular Communication and Nanonetworks Biomedical Engineering 0 works
  10. 10 Microbial Metabolic Engineering and Bioproduction Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available55.6%not open44.4%

World: 28% of research is openly available.

with international co-authors25.2%domestic only74.8%

World: 19% is written across borders.

How has Genexine (South Korea)'s research output changed?

Output in 2018–2022 was 24% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seongnam-si

All research institutions in Seongnam-si

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.